LEUKEMIA, B-CELL
Clinical trials for LEUKEMIA, B-CELL explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, B-CELL trials appear
Sign up with your email to follow new studies for LEUKEMIA, B-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lifeline for patients: extended ibrutinib access trial launches
Disease control OngoingThis study offers ongoing access to the drug ibrutinib for people with certain blood cancers or graft-versus-host disease who completed earlier ibrutinib trials and are still seeing benefits. Participants continue their treatment while researchers collect long-term safety informa…
Matched conditions: LEUKEMIA, B-CELL
Phase: PHASE4 • Sponsor: Pharmacyclics Switzerland GmbH • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Gene therapy patients monitored for 15 years in safety follow-up
Knowledge-focused ENROLLING_BY_INVITATIONThis study does not provide any new treatment. It follows up to 1,000 adults who previously received CAR T-cell gene therapy for blood cancers like lymphoma, leukemia, or multiple myeloma. The goal is to watch for long-term side effects, as required by regulators. Participants wi…
Matched conditions: LEUKEMIA, B-CELL
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 07, 2026 18:41 UTC